Revolutionizing Drug Development: FDA’s Shift from Animal Testing Sets the Stage for Innovation in Medicines Development
Seizing Opportunities in a Changing Medicines Landscape: What EMANS 2028 Means for the Future of Pharmaceutical Leadership